Guoqiang Fu
-
- Phytochemicals and Antioxidant Activities 2
-
- Atrial Fibrillation Management and Outcomes 2
- Cardiac, Anesthesia and Surgical Outcomes 2
-
- Natural product bioactivities and synthesis 2
-
- Natural Antidiabetic Agents Studies 2
-
- Asthma and respiratory diseases 2
-
- Nausea and vomiting management 1
-
- Cancer Mechanisms and Therapy 1
Guoqiang Fu
23 papers receiving 497 citations
Peers
Comparison fields: 5 of 93
- Cancer Research 74
- Pharmacology 42
- Biochemistry 28
- Cardiology and Cardiovascular Medicine 96
- Molecular Biology 234
Countries citing papers authored by Guoqiang Fu
This map shows the geographic impact of Guoqiang Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoqiang Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoqiang Fu more than expected).
Fields of papers citing papers by Guoqiang Fu
This network shows the impact of papers produced by Guoqiang Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoqiang Fu. The network helps show where Guoqiang Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guoqiang Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 9 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 12 | |
| 5 | 2020 | 4 | |
| 6 | 2019 | 129 | |
| 7 | 2017 | 1 | |
| 8 | 2014 | 6 | |
| 9 | 2013 | 10 | |
| 10 | 2012 | 13 | |
| 11 | 2012 | 38 | |
| 12 | 2012 | 67 | |
| 13 | 2012 | 24 | |
| 14 | 2012 | 21 | |
| 15 | Inhibition potential of glimepiride (gli) towards important UDP-glucuronosyltransferase (UGT) isoforms in human liver. | 2012 | 2 |
| 16 | 2012 | 17 | |
| 17 | 2010 | 1 | |
| 18 | 2010 | 64 | |
| 19 | 2010 | 49 | |
| 20 | 2009 | 11 |
About Guoqiang Fu
Guoqiang Fu is a scholar working on Pharmacology, Biochemistry and Cardiology and Cardiovascular Medicine, having authored 23 papers that have together received 507 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (2 papers), Natural product bioactivities and synthesis (2 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers), Phytochemicals and Antioxidant Activities (2 papers), Natural Antidiabetic Agents Studies (2 papers), Asthma and respiratory diseases (2 papers), Nausea and vomiting management (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Cancer Research (74 citations), Pharmacology (42 citations) and Biochemistry (28 citations). Guoqiang Fu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Boliang Wang, Yanyang Tu, Qi Wang, Jianbo Xiao, Gang Wang, Jianfang Fu, Jun Yuan, Nanyan Zhang, Bin Gao and Xinggang Mao. Their work appears in journals such as Clinical & Translational Oncology, International Journal of Surgery, International Journal of Biological Macromolecules, Food Chemistry and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.